story of the week
Oral Semaglutide vs Subcutaneous Liraglutide and Placebo in Type 2 Diabetes (PIONEER 4)
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet